Bank of Montreal
DGX icon

Bank of Montreal’s Quest Diagnostics DGX Stock Holding History

Bank of Montreal’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,200
Closed -$6.71M – 3922
2024
Q2 		$6.71M Buy
+46,200
New +$6.33M ﹤0.01% 1156
2023
Q4 		– Sell
-11,000
Closed -$1.47M – 4033
2023
Q3 		$1.47M Buy
+11,000
New +$1.47M ﹤0.01% 1861

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Bank of Montreal's DGX Position: Q1 2026 in Review

Bank of Montreal reduced its Quest Diagnostics (DGX) stake by 3.2% in Q1 2026, selling an estimated $1.36M and leaving 210,365 shares worth $41.2M. The position accounts for 0.02% of the portfolio, ranked #604.

Bank of Montreal first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $51M in Q4 2021. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Bank of Montreal held 210,365 shares of Quest Diagnostics worth $41.2M as of Q1 2026.
  • Bank of Montreal sold 7,019 Quest Diagnostics shares in Q1 2026, an estimated $1.36M.
  • Quest Diagnostics made up 0.02% of Bank of Montreal's portfolio in Q1 2026, its #604 holding.
  • Bank of Montreal first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Quest Diagnostics position peaked at $51M in Q4 2021.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.